Evidence map›Paper›PMID 41326810›Full record

ReviewActa pharmacologica Sinica2026

Roles and related underlying mechanisms of mitochondrial RNA modification in cancer progression.

Ling-Zhi Wang, Tao-Yu Yang, Zi-Hui Xiong, Jian-Xin Peng, Jia-Wang Zhou, Hong-Sheng Wang, Jun-Ming He

Abstract readReview
In one paragraph

Review in Acta pharmacologica Sinica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ling-Zhi Wang *Department of Anesthesiology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510260, China.
Tao-Yu Yang *The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.
Zi-Hui XiongDepartment of Hepatobiliary Surgery, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China.
Jian-Xin PengDepartment of Hepatobiliary Surgery, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China.
Jia-Wang ZhouGuangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China. zhoujw77@mail.sysu.edu.cn.
Hong-Sheng WangGuangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, China. whongsh@mail.sysu.edu.cn.
Jun-Ming HeDepartment of Hepatobiliary Surgery, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China. hejunming0101@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitochondrial RNA modifications refer to modifications that occur across various RNA species within the mitochondria. While the incidence of such modifications is lower than that in the cytoplasm, substantial evidence highlights their pivotal role in facilitating mitochondrial gene expression and precise protein synthesis. Emerging research suggests that these mitochondrial RNA modifications are also significantly involved in the progression of cancer. In this review, we first delve into the diversity of mitochondrial RNA modifications, their potential sites of occurrence, and the enzymes involved in these processes. We evaluate the existing evidence regarding mitochondrial RNA modifications and their significance in cancer progression and investigate the potential of these modifications as promising targets for both preventative strategies and early diagnostic screening. Finally, we deliberate on the trajectory of mitochondrial RNA modifications in the context of cancer progression and how these RNA modifications might pave the way for novel diagnostic and therapeutic approaches for preventive medicine.

Indexed as

MitochondriaNeoplasmsRNARNA, MitochondrialRNA Processing, Post-TranscriptionalAnimalsDisease ProgressionHumansRNARNA, MitochondrialcancermethylationmitochondriaRNA modifications

Identifiers

PMID41326810
PMCPMC13018551

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.